Concepedia

Michel DuPage

MD

14

Publications

4.7K

Citations

14

H-Index

2008

Active since

Affiliations

Massachusetts Institute of Technology(Current)

Howard Hughes Medical Institute

University of California, Berkeley

University of California, San Francisco

Harvard University

Michel DuPage is an author at Massachusetts Institute of Technology specializing in medicine, immunology, and immunotherapy.

Top concepts

MedicineImmunologyImmunotherapyCell BiologyTumor BiologyTumor ImmunityTumor MicroenvironmentImmuno-oncologyLung CancerAutoimmunity

Publications per year

2008–2024

14

Publications

14

Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase

Michel DuPage, Alison L. Dooley, Tyler Jacks · Nature Protocols · 2009 · 918 citations · Full text

Cre Recombinase, Tumor Biology, Lentiviral Delivery +8

MHC-II neoantigens shape tumour immunity and response to immunotherapy

Elise Alspach, Danielle M. Lussier, Alexander P. Miceli et al. · Nature · 2019 · 837 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Mhc-ii Neoantigens +6

Expression of tumour-specific antigens underlies cancer immunoediting

Michel DuPage, Claire Mazumdar, Leah Schmidt et al. · Nature · 2012 · 520 citations

Tumor Biology, Tumor Immunology, Cancer Immunosurveillance +8

Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses

Nikhil S. Joshi, Elliot H. Akama‐Garren, Yisi Lu et al. · Immunity · 2015 · 490 citations · Full text

Cancer Immunosurveillance, T-regulatory Cell, Immunology +8

Suppression of lung adenocarcinoma progression by Nkx2-1

Monte M. Winslow, Talya L. Dayton, Roel G.W. Verhaak et al. · Nature · 2011 · 473 citations

Medicine, Immunology, Lung Adenocarcinoma Progression +4

Rows per page

1–5 of 14